Filing Details
- Accession Number:
- 0002021477-25-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-15 14:02:44
- Reporting Period:
- 2025-04-10
- Filing Date:
- 2025-04-15
- Accepted Time:
- 2025-04-15 14:02:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1041024 | Rockwell Medical Inc. | RMTI | Pharmaceutical Preparations (2834) | 383317208 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2022157 | Trust Investment Family Larson Irrevocable | 3608 Lexington Ave. Dallas TX 75205 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-10 | 4,000 | $1.06 | 3,474,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 4,000 | $1.08 | 3,478,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.05 | 3,480,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.08 | 3,482,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.08 | 3,484,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 6,000 | $1.07 | 3,490,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.07 | 3,492,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 7,000 | $1.07 | 3,499,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 10,000 | $1.10 | 3,509,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.04 | 3,511,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.05 | 3,513,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.05 | 3,515,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.04 | 3,517,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 4,000 | $1.06 | 3,521,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.06 | 3,523,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.07 | 3,525,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 2,000 | $1.09 | 3,527,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.08 | 3,529,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 1,000 | $1.09 | 3,530,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.07 | 3,532,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.07 | 3,534,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.08 | 3,536,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.08 | 3,538,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.08 | 3,540,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 4,000 | $1.09 | 3,544,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 1,500 | $1.09 | 3,545,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.10 | 3,547,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.06 | 3,549,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 6,000 | $1.08 | 3,555,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 2,000 | $1.09 | 3,557,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
